Here, we took a reverse approach not based on inhibition of the Pyrin inflammasome (by colchicine) but on activation of the Pyrin inflammasome, which we demonstrated to be specific for FMF patients’ monocytes following PKC superfamily inhibitor addition. This evidence concerns the gene PRRT2 and familial Mediterranean fever.